Page 5 - Concept Study News Today

Mitsui O.S.K. Lines and Mitsubishi Shipbuilding Co. announced that they have completed a concept stu...

New data on lecanemab to be presented at the 14th Clinical Trials on Alzheimer's Disease (CTAD) conference - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and partner Eisai today announced that they will hold several oral presentations revealing new...

STOCKHOLM, Nov. 4, 2021 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and partner Eisai today announced that they will hold several oral presentations revealing new data on

Mitsui O.S.K. Lines, Ltd. in cooperation with Mitsubishi Shipbuilding Co., Ltd. of the Mitsubishi Heavy Industries Group, have completed Concept Study of the multiple hull forms for a liquefied CO2 (LCO2) carrier that can potentially be the mainstream in the LCO2 shipping market in the near future. LCO2 carriers will play an important role in ...

New NASA green airliner study to go beyond agency’s sustainable X-plane to include technology for broader reduced environmental impacts.

Confirms Red Chris potential to become a world class, long life mineEstimated 17% IRR and C$2.3 billion NPV over an initial 31 year mine life1,2,3Projected average 316kozpa gold and 80ktpa copper production

AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology ABBVie today announced that it will present new data from a total of 41 abstracts covering its portfolio of immunology assets, including RINVOQ ® SKYRIZI ® HUMIRA ® and its pipeline across multiple rheumatic diseases at the EULAR 2021 Virtual Congress of Rheumatology, to be held virtually June 2-5 . Among the data presented will be new three-year and one-year ef...

Recce Pharmaceuticals (ASX:RCE) makes first steps towards new trials SubscribeBe the first with the news that moves the market Recce Pharmaceuticals (RCE) has lodged an application to commence human clinical trials for its topical burns treatment, RECCE 327 The ASX-lister announced it had registered for the trial with the Australian and New Zealand Clinical Trial Registry for a phase I/II topical burns study The study is set to test 30 patients over two weeks in a bid to test the efficacy of th...

NCM Announces Red Chris Receives Regulatory and Funding Approval Newcrest Mining Limited is pleased to announce that it has commenced construction of the box-cut for the exploration decline at its Red Chris mine in British Columbia, following receipt of the necessary regulatory approvals. The Newcrest Board has also approved C$135 million of funding for the construction of the exploration decline and associated infrastructure and permitting costs. These works are expected to … Newcrest Mining...